Physician

Kathryn B Alguire, M.D.

According to 2025 Medicare claims, Kathryn Alguire, M.D. (NPI: 1568468882) practices medical oncology in the Muskegon-Norton Shores, MI market, with the plurality of this provider's patient population coming from Muskegon, MI. This provider's primary affiliated billing organization is CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (NPI: 1528018389; TIN: 382777354) and primary practice location at 49444-9739. Alguire is affiliated with the Trinity Health Integrated Care (ACO ID: A3454) and West Michigan Accountable Care Organization, LLC (ACO ID: A4626), participating under the MSSP model.

Alguire's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 535 traditional Medicare patients, billed 121,660 HCPCS/CPT codes, and received $1,850,778 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 3,672 prescription claims across 747 beneficiaries totaling $9,736,730 in drug costs, led by Ibrance (Palbociclib). DME data shows 68 claims. Open Payments data shows 43 records totaling $930. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $3,377,421 to $9,736,730. In contrast, DME billing represents a smaller volume and moved sharply higher in recent years, from $4,117 to $7,991.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	710	234,440	$2,537,218
2016	659	194,156	$2,450,531
2017	839	209,458	$3,167,994
2018	752	202,777	$3,217,538
2019	787	195,296	$3,436,901
2020	722	172,683	$3,393,390
2021	588	184,584	$2,996,190
2022	572	151,470	$2,926,007
2023	536	158,782	$2,333,608
2024	535	121,660	$1,850,778

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	440	2,564	$3,377,421
2016	449	2,714	$3,739,174
2017	540	3,442	$6,106,152
2018	552	3,628	$7,031,614
2019	535	3,351	$8,280,667
2020	566	3,290	$9,257,376
2021	627	3,100	$7,863,496
2022	682	3,324	$9,347,812
2023	715	3,290	$7,645,813
2024	747	3,672	$9,736,730

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	72	$26,361
2016	N/R	86	$35,363
2017	N/R	72	$25,262
2018	N/R	13	$871
2019	N/R	80	$7,520
2020	N/R	13	$2,143
2021	N/R	11	$1,286
2022	N/R	11	$884
2023	N/R	14	$11,110
2024	N/R	68	$2,572

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	101	220	$93
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	267	416	$57
80053	Blood test, comprehensive group of blood chemicals	150	604	$10
36415	Insertion of needle into vein for collection of blood sample	197	740	$9
85025	Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count	157	693	$8

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Ibrance	Palbociclib	124	3,458	$1,859,453
Lenalidomide	Lenalidomide	65	1,820	$982,157
Imbruvica	Ibrutinib	72	2,070	$954,093
Verzenio	Abemaciclib	62	1,736	$855,245
Revlimid	Lenalidomide	38	1,015	$619,729

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0656	Segmental pneumatic appliance for use with pneumatic compressor, trunk	Y	N/R	21	$989
E0657	Segmental pneumatic appliance for use with pneumatic compressor, chest	Y	N/R	21	$929
J8521	Capecitabine, oral, 500 mg	N	N/R	14	$491
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	12	$163

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	43	$930	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Kathryn B. Alguire, M.D.?

Tedicare shows public-source Medicare data for Kathryn B. Alguire, M.D. (NPI 1568468882), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Kathryn B. Alguire, M.D. have ACO affiliation data?

Kathryn B. Alguire, M.D. is shown with ACO affiliation data for Trinity Health Integrated Care (MSSP, ACO ID A3454) and West Michigan Accountable Care Organization, LLC (MSSP, ACO ID A4626).

What billing organization is linked to Kathryn B. Alguire, M.D.?

Kathryn B. Alguire, M.D. is linked to CANCER & HEMATOLOGY CENTERS OF WESTERN MI, P.C. (billing NPI 1528018389) in the available physician profile data.

Does Kathryn B. Alguire, M.D. have Open Payments data?

Kathryn B. Alguire, M.D. has 43 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.